60 likes | 67 Views
Plexiform Neurofibromas Treatment Market is Expected to Showcase a Significant Growth by 2030 | AstraZeneca, Pfizer Inc., Sun Pharmaceuticals Industries Limited<br>
E N D
PlexiformNeurofibromas Treatment Market Market Size (2022) US$ 1,371.14 MN CAGR (2023 – 2030) 8.2% Market Size (2030) US$ 2,576.19 MN
Segmentation (Scope) By Drug Class: By Distribution Channel By Patient Population: • Selumetinib • Pediatric • Hospitals Pharmacies • Non-Steroidal • Anti-Inflammatory Drugs • Adult • Retail Pharmacies • Anticonvulsants • Online Pharmacies • Others © Coherent Market Insights. All Rights Reserved
Major Drivers • Increasing strategies adopted by key market players such as product approval by regulatory authorities • Lack of approved drugs for the treatment of neurofibromatosis Type 1 © Coherent Market Insights. All Rights Reserved
Merck & Co., Inc., • American Regent, Inc., • McKesson Medical-Surgical Inc., • GNHIndia.com, • Lexicon Medical Supply, • Medline Industries, Inc., • Caspian Tamin Pharmaceutical Co., • Sandoz Canada Inc, • NorthWestPharmacy.com Inc., • MediscaInc, ExelaPharma Sciences, • LLC, Sanofi Pasteur Inc., • Sorrento Therapeutics Inc. Major Players © Coherent Market Insights. All Rights Reserved
Global PlexiformNeurofibromas Treatment Market-Share (%), By Route, 2030 2030 © Coherent Market Insights. All Rights Reserved